Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denti

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
CPT: Pharmacometrics & Systems Pharmacology|June 10, 2017
Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After DeliveryM de Kock, J Tarning, L Workman, et al.
Minerva Cardioangiologica|October 11, 2011
Patient selection for MitraClip therapy impaired left ventricular systolic functionF Maisano, C Godino, A Giacomini, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 2022
Altered drug exposures of first-line TB drugs in a moxifloxacin-containing treatment regimenR Perumal, O Arodola-Oladoyinbo, A Naidoo, et al.
Perfusion|February 3, 2009
A cardioplegia circuit with versatility: the 'ReVerse' system. How to do itN Colangelo, S Moriggia, T Kieser, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2025
Model-based evaluation of adherence to bedaquiline and clofazimine in adults with drug-resistant TBJ E Resendiz-Galvan, R A Murphy, T Govender, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 30, 2013
Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of AfricaG Pillai, G Davies, P Denti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individualsE H Decloedt, J Mwansa-Kambafwile, J-S van der Walt, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2023
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic ModelingM T Chirehwa, J E Resendiz-Galvan, R Court, et al.
IJTLD Open|March 18, 2026
Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER studyN Abdelgawad, M Chirehwa, H McIlleron, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
CPT: Pharmacometrics & Systems Pharmacology|June 10, 2017
Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After DeliveryM de Kock, J Tarning, L Workman, et al.
Minerva Cardioangiologica|October 11, 2011
Patient selection for MitraClip therapy impaired left ventricular systolic functionF Maisano, C Godino, A Giacomini, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 2022
Altered drug exposures of first-line TB drugs in a moxifloxacin-containing treatment regimenR Perumal, O Arodola-Oladoyinbo, A Naidoo, et al.
Perfusion|February 3, 2009
A cardioplegia circuit with versatility: the 'ReVerse' system. How to do itN Colangelo, S Moriggia, T Kieser, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2025
Model-based evaluation of adherence to bedaquiline and clofazimine in adults with drug-resistant TBJ E Resendiz-Galvan, R A Murphy, T Govender, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 30, 2013
Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of AfricaG Pillai, G Davies, P Denti, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individualsE H Decloedt, J Mwansa-Kambafwile, J-S van der Walt, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2023
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic ModelingM T Chirehwa, J E Resendiz-Galvan, R Court, et al.
IJTLD Open|March 18, 2026
Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER studyN Abdelgawad, M Chirehwa, H McIlleron, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 2, 2022
Clinical standards for the dosing and management of TB drugsJ W C Alffenaar, S L Stocker, L Davies Forsman, et al.
Pageof 2